Collaborative Research Project List
The research unit of the UCSF-Stanford CERSI stimulates innovative and collaborative research in regulatory science among FDA scientists, academic scientists, and scientists in the biotechnology and pharmaceutical industries. Active and completed collaborative research projects are organized into categories as shown below.
CERSI Principal Investigator: Ngan Huang, PhD (Stanford)
FDA Collaborators: Kyung Sung, PhD (CBER/FDA)
Status: Active
Completed Projects
CERSI Principal Investigator: Sean Bendall, PhD (Stanford)
FDA Collaborators: Steven Bauer, PhD (CBER/FDA)
Status: Completed
CERSI Principal Investigator: Eric Kool, PhD (Stanford)
FDA Collaborators: Jaroslav Vostal, MD, PhD (CBER/FDA), Chintamani Atreya,PhD (CBER/FDA)
Status: Completed
Project #27: An Unbiased Analysis of Identification and Assessment of Cas9/gRNA Potential Off-Target Sites in Clinical Development of Ex Vivo Manufactured Genome Edited Cell Products
CERSI Principal Investigator: Matthew Porteus, MD, PhD (Stanford)
FDA Collaborators: Zhaohui Ye, PhD (CBER/FDA)
Status: Completed
CERSI Principal Investigator: Utkan Demirci, PhD (Stanford)
FDA Collaborators: Indira Hewlett, PhD (CBER/FDA), Mohan Haleyurgirisetty, PhD (CBER/FDA), Jiangqin Zhao, PhD (CBER/FDA)
Status: Completed
CERSI Principal Investigator: Tina Hernandez-Boussard, PhD, MPH, MS (Stanford)
FDA Collaborators: Barbee Whitaker, PhD (CBER/FDA), Steven Anderson, PhD, MPP (CBER/FDA), Artur Belov, PhD (CBER/FDA), Hui-Lee Wong, PhD (CBER/FDA)
Status: Completed
Project #39: Development of New Machine Learning Algorithms to Quantify Treatment Effectiveness and Adverse Outcomes
CERSI Principal Investigator: James Zou, PhD (Stanford)
FDA Collaborators: Steven Anderson, PhD, MPP (CBER/FDA), Barbee Whitaker, PhD (CBER/FDA), Alan Williams, PhD (CBER/FDA), Gregory Pappas, MD, PhD (CBER/FDA), Angela Moy (CBER/FDA)
Status: Completed
Project #41: Using the University of California Clinical Data Warehouse to Evaluate the Safety and Efficacy of Biologics, including Blood Transfusions, Vaccines, CAR-T cell Therapies, and other CBER Regulated Products
CERSI Principal Investigator: Atul Butte, MD, PhD (UCSF)
FDA Collaborators: Barbee Whitaker, PhD (CBER/FDA), Steven Anderson, PhD, MPP (CBER/FDA), Artur Belov, PhD (CBER/FDA), Hui-Lee Wong, PhD (CBER/FDA)
Status: Completed | Plain Language Summary
Project #60: Improving Adverse Event Detection Related to Biologic Immunosuppressant Use – A Pilot Study of the BERT Deep Learning Model Adapted to Real-world Clinical Notes
CERSI Principal Investigators: Vivek Rudrapatna, MD, PhD (UCSF), Atul Butte, MD, PhD (UCSF), Ludwig, Dana, MD (UCSF)
FDA Collaborators: Samer El-Kamary, MD, MPH (CDER/FDA), Jawahar Tiwari, PhD (CBER/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Laura Esserman, MD, MBA (UCSF)
FDA Collaborators: Mitra Rocca, Dipl Inform Med (CDER/FDA), Jacqueline Corrigan-Curay, JD, MD (CDER/FDA), Dianne Paraoan (CDER/FDA), Frank Weichold, MD, PhD (ORSI/FDA), Paul Kluetz, MD (OCE/FDA), Gideon (Scott) Gordon, PhD (CDER/FDA)
Status: Active
CERSI Principal Investigator: Katherine Yang, PharmD, MPH (UCSF)
FDA Collaborators: Lei Zhang, PhD (CDER/FDA), Eleftheria Tsakalozou, PhD (CDER/FDA)
Status: Active
CERSI Principal Investigators: Russ Altman (Stanford)
FDA Collaborators: Liang Zhao (OGD), Meng Hu (OGD)
Status: Active
CERSI Principal Investigators: Jim Wells, PhD (UCSF)
FDA Collaborators: Jeff Summers (CDER), Wenming Xiao (CDER), Martha Donoghue (CDER), Kristin Wessel (CDER), Mike Norcross (CDER), Li-Rong Yu (NCTR), Rebekah Zinn (OCE)
Status: Active
CERSI Principal Investigators: Rohit Vashisht, PhD (UCSF)
Status: Active
Completed Projects
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Steve Anderson, PhD, MPP (CBER/FDA), Robert Ball, MD, MPH (CDER/FDA), Ruth Barratt, PhD, DVM (CDER/FDA), Mitra Rocca, Dipl Inform Med (CDER/FDA), Carol Pamer, RPh, MPH (CDER/FDA), Scott Proestel, MD (CDER/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Nigam Shah, MBBS, PhD (Stanford)
FDA Collaborators: Ruth Barratt, PhD, DVM (CDER/FDA), Henry Francis, MD (CDER/FDA), Ana Szarfman, MD, PhD (CDER/FDA), Isaac Chang, MD, PhD (CDRH/FDA), Joseph Tonning, MD (CDER/FDA), Robert Ball, MD, MPH (CDER/FDA), Mitra Rocca, Dipl Inform Med (CDER/FDA
Status: Completed
CERSI Principal Investigator: Laura Esserman, MD, MBA (UCSF)
FDA Collaborators: Mitra Rocca, Dipl Inform Med (CDER/FDA), Ronald Fitzmartin, PhD, MBA (CDER/FDA), Fatima Frye (CDER/FDA), MaryAnne Slack (CDER/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Brian Shoichet, PhD (UCSF)
FDA Collaborators: Andrew Babiskin, PhD (CDER/FDA), Robert Dorsam, PhD (CDER/FDA), Victoria Keck, MHA (CDER/FDA), Zhanglin Ni, PhD (CDER/FDA), Eleftheria Tsakalozou, PhD (CDER/FDA), Liang Zhao, PhD (CDER/FDA), Susan Zuk, MS (CDER/FDA)
Status: Completed | Excipient Browser | Usage Statistics of Excipient Browser | Plain Language Summary
CERSI Principal Investigator: Kathy Giacomini, PhD (UCSF)
FDA Collaborators: Andrew Babiskin, PhD (CDER/FDA), Sruthi King, PhD (CDER/FDA), Zhanglin Ni, PhD (CDER/FDA), Eleftheria Tsakalozou, PhD (CDER/FDA), Liang Zhao, PhD (CDER/FDA), Susan Zuk, MS (CDER/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Sonja Brajovic, MD (CDER/FDA), Todd Bridges, RPh (CDER/FDA), Carol Pamer, RPh, MPH (CDER/FDA), Jim Schlick, RPh, MBA (CDER/FDA), Jo Wyeth, PharmD (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Peter Turnbaugh, PhD (UCSF)
FDA Collaborators: Roselie Bright, ScD, MS, PMP (OHI/FDA), Elaine Johanson (OHI/FDA)
Status: Completed
CERSI Principal Investigator: Steve Goodman, MD, MHS, PhD (Stanford)
FDA Collaborators: Telba Irony, PhD (CBER/FDA), Tom Permutt, PhD (CDER/FDA), Estelle Russek-Cohen, PhD (CDER/FDA)
Status: Completed
Project #30: Healthy Citizen Hospital Pilot
CERSI Principal Investigator: Ida Sim, MD, PhD (UCSF)
FDA Collaborators: Elaine Johanson (OHI/FDA), Ameeta Parekh, PhD (CDER/FDA)
Status: Completed
CERSI Principal Investigators: Kevin Healy, PhD (UC Berkeley), Edward Hsiao, MD, PhD (UCSF)
FDA Collaborators: Alexandre Ribeiro, PhD (CDER/FDA), David Strauss, MD, PhD (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Sook Wah Yee, PhD (UCSF)
FDA Collaborators: Shiew Mei Huang, PhD (CDER/FDA), Qi Liu, PhD (CDER/FDA), Lei Zhang, PhD (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Daniel Rubin, MD, MS (Stanford)
FDA Collaborators: Qi Liu, PhD, MStat, FCP (CDER/FDA), Yaning Wang, PhD, MStat (CDER/FDA), Hao Zhu, PhD, MStat (CDER/FDA), M. Khair ElZarrad PHD, MPH (CDER/FDA), Matthew Diamond, MD, PhD (CDRH/FDA)
Status: Completed
Project #69: Effects of Antioxidants in Drugs Products on Intestinal Drug Transporters
CERSI Principal Investigators: Sook Wah Yee, PhD (UCSF), Deanna Kroetz, PhD (UCSF) (Co-PI)
FDA Collaborators: Liang Zhao, PhD (CDER/OGD/FDA), Lei Zhang, PhD (CDER/OGD/FDA), Khondoker Alam, PhD (CDER/OGD/FDA)
Status: Completed
CERSI Principal Investigator: Christopher Almond (Stanford), Chandra Ramamoorthy (Stanford)
FDA Collaborators: Nilsa Loyo-Berrios, PhD (CDRH/FDA), Malvina Eydelman, MD (CDRH/FDA), Rebecca Torguson, MPH (CDRH/FDA), Christine Merenda (OMHHE/FDA), Allison O'Neill, PhD (CDRH/FDA), Gene Pennello, PhD (CDRH/FDA), Rebecca Ward, PhD (CDRH/FDA), Vasum Peiris, MD, (CDRH/FDA), Michelle Tarver, MD, PhD (CDRH/FDA), Damia Jackson (CDRH/FDA)
Status: Active | Plain Language Summary
Project #78: Improving the Integrity of Novel Digital Health Technology-Derived Endpoints Through Rigorous Simulation Studies of Multiple Imputation
CERSI Principal Investigator: Manisha Desai (Stanford)
FDA Collaborators: Maria Matilde Kam (CDER), Andrew Potter (CDER), Paul Schuette (CDER), Lili Garrard (CDER)
Status: Active
Project #83: Pathogen reduction of whole blood using silicon nanopore membrane-based filtration system (SNM-FS)
CERSI Principal Investigator: Shuvo Roy (UCSF)
FDA Collaborators: Carlos Villa (CBER), David McGivern (CBER)
Status: Active
Completed Projects
CERSI Principal Investigator: Jeffrey Lotz, PhD (UCSF)
FDA Collaborators: Anton Dmitriev, PhD (CDRH/FDA), Srinidhi Nagaraja, PhD (CDRH/FDA), Jonathan Peck, MS (CDRH/FDA)
Status: Completed | Plain Language Summary
Project #26: Developing Frameworks and Tools for Integration of Digital Health Tools into Clinical Practice
CERSI Principal Investigator: Andrew Auerbach, MD (UCSF)
FDA Collaborators: Bakul Patel, MS, MBA (CDRH/FDA), Vinay Pai, PhD (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Xiao Hu, PhD (UCSF)
FDA Collaborators: Christopher Scully, PhD (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Jeffrey Lotz, PhD (UCSF)
FDA Collaborators: Anton Dmitriev, PhD (CDRH/FDA), Andrew Baumann, PhD (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Shuvo Roy, PhD (UCSF)
FDA Collaborators: Qijin Lu, PhD (CDRH/FDA), Megan Jamiolkowski, PhD (CDRH/FDA), Richard Malinauskas, PhD (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Jean Feng, PhD (UCSF)
FDA Collaborators: Berkman Sahiner, PhD (CDRH/FDA), Alexej Gossmann, PhD, CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Sanket Dhruva, MD, MHS (UCSF)
FDA Collaborators: Hetal Odobasic, MS (CDRH/FDA), Li Wang, PhD, MBA, MS (CDRH/FDA), Jacqueline M. Major, PhD (CDRH/FDA)
Status: Completed
Project #65: The Digital Variome: Understanding the Implications of Digital Tools on Health
CERSI Principal Investigator: Andrew Auerbach, MD (UCSF)
FDA Collaborators: Leeda Rashid, MD, MPH (CDRH/FDA), Anindita Saha, (CDRH/FDA), Bakul Patel, MS, MBA (CDRH/FDA), Cathy Bahr (CDRH/FDA), Vinay Pai, PhD (CDRH/FDA), Arti Tandon, PhD (CDRH/FDA), JiPing Chen, MD, PhD (CDRH/FDA), Charles Yongpravat (CDRH/FDA), Aubrey Shick, MS (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Nigam Shah, MBBS, PhD (Stanford)
FDA Collaborators: Anindita Saha (CDRH/FDA), Bakul Patel, MS, MBA (CDRH/FDA), MiRa Jacobs, PhD (CDRH/FDA), Vinay Pai, PhD (CDRH/FDA), Aubrey Shick, MS (CDRH/FDA), Gloria Nyankima, PhD, (CDRH/FDA), Jessica Paulsen (CDRH/FDA), Kan Fang, MD (CDRH/FDA),,Charlie Yongpravat (CDRH/FDA)
Status: Completed
Project #70: Prospective Clinical Study of Pulse Oximeter Errors in Hospitalized Patients
CERSI Principal Investigator: Philip Bickler, MD (UCSF), Michael Lipnick, MD (UCSF)
FDA Collaborators: Nilsa Loyo-Berrios, PhD (CDRH/OPEQ/OCEA/FDA), Malvina Eydelman, MD (CDRH/OPEQ/OHT1/FDA), Rebecca Torguson, MPH (CDRH/OPEQ/OHT1/FDA), Christine Merenda (OMHHE/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Sean Mackey, MD, PhD (Stanford)
FDA Collaborators: Michelle Tarver, MD, PhD (CDRH/FDA), Anindita Saha (CDRH/FDA), David Gebben, PhD (CDRH/FDA), Heather Benz, PhD (CDRH/FDA)
Status: Active
Project #63: Development, Implementation, and Evaluation of an Open Source Software Program to Support Patient-based Estimation of Clinically Meaningful Levels and Change Scores for Patient Reported Outcome Measures
CERSI Principal Investigator: Sean Mackey, MD, PhD (Stanford)
FDA Collaborators: Fraser Bocell, PhD (CDRH/OST/FDA), Michelle Tarver, MD, PhD (CDRH/FDA), Allen Chen, PhD (CDRH/FDA)
Status: Active
Completed Projects
CERSI Principal Investigator: Kuldev Singh, MD, MBA (Stanford)
FDA Collaborators: Malvina Eydelman, MD (CDRH/FDA) Michelle Tarver, MD, PhD (CDRH/FDA)
Status: Completed | Plain Language Summary
Project #17: Comparing Qualitative and Quantitative Approaches for Eliciting Patient Preference on Upper Limb Prostheses: A Case Study on Innovative Upper Limb Prostheses
CERSI Principal Investigator: Leslie Wilson, PhD (UCSF)
FDA Collaborators: Eugene Civillico, PhD (CDRH/FDA), Telba Irony, PhD (CBER/FDA), Xuefeng Li, PhD (CDRH/FDA), Anindita Saha (CDRH/FDA)
Status: Complete | Plain Language Summary
CERSI Principal Investigator: Korey Hood, PhD (Stanford)
FDA Collaborators: Heather Benz, PhD (CDRH/FDA), Martin Ho, MSc (CDRH/FDA), Vasum Peiris, MD, MPH (CDRH/FDA), Anindita Saha (CDRH/FDA)
Status: Complete
CERSI Principal Investigator: Courtney Lyles, PhD (UCSF), Urmimala Sarkar, MD, MPH (UCSF)
FDA Collaborators: Fraser Bocell, PhD (CDRH/FDA), Michelle Tarver, MD PhD (CDRH/FDA), Brittany Caldwell, PhD (CDRH/FDA), Annie Saha (CDRH/FDA), Martin Ho, MSc (CDRH/FDA)
Status: Complete
CERSI Principal Investigator: Christopher Almond, MD, MPH (Stanford)
FDA Collaborators: Fraser Bocell, PhD (CDRH/FDA), Vasum Peiris, MD, MPH (CDRH/FDA), Michelle Tarver, MD, PhD (CDRH/FDA), Brittany Caldwell, PhD (CDRH/FDA), Anindita Saha (CDRH/FDA), Martin Ho, MSc (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Geoffrey Sonn, MD (Stanford)
FDA Collaborators: Charles Viviano, MD, PhD (CDRH/FDA), David Gebben, PhD (CDRH/FDA), Olufemi Babalola, MSc, MHS (CDRH/FDA)
Status: Complete
CERSI Principal Investigator: Charles Chiu, MD, PhD (UCSF)
FDA Collaborators: Indira Hewlett, PhD (CBER/FDA)
Status: Active
CERSI Principal Investigator: Joseph Wu, PhD (Stanford)
FDA Collaborators: David Strauss, MD, PhD (CDER/OTS/OCP/FDA), Alexandre Ribeiro, PhD (CDER/FDA), Rodney Rouse, DVM (CDER/OTS/OCP/FDA), Kevin Ford, PhD (CDER/FDA)
Status: Active
CERSI Principal Investigator: Joseph Wu, MD, PhD (Stanford)
FDA Collaborators: David Strauss (CDER/FDA), Kevin Ford (CDER/FDA), Dylan Bruckner (CDER/FDA)
Status: Active
CERSI Principal Investigator: Joseph Wu, MD, PhD (Stanford)
FDA Collaborators: Laleh Amiri-Kordestani (CDER/FDA), Kevin Ford (CDER/FDA), Margret Merino (CDER/FDA) , Julie Schneider (OCE/FDA)
Status: Active
CERSI Principal Investigator: Nadav Ahitiv, PhD (UCSF)
Status: Active
Completed Projects
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Elaine Johanson (OHI/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Roselie Bright, ScD (OHI/FDA), Larry Callahan, PhD (OHI/FDA), Elaine Johanson (OHI/FDA), Frank Switzer, PhD (OHI/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Snehit Prabhu, PhD (Stanford)
FDA Collaborators: Adam Berger, PhD (CDRH/FDA), Roselie Bright, ScD, MS, PMP (OHI/FDA), Elaine Johanson (OHI/FDA), Samir Lababidi, PhD (OHI/FDA), David Litwack, PhD (CDRH/FDA), Zivana Tezak, PhD (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Dmitri Petrov, PhD (Stanford)
FDA Collaborators: Elaine Johanson (OHI/FDA)
Status: Completed
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Michael Pacanowski, PharmD, MPH (CDER/FDA), Anuradha Ramamoorthy, PhD (CDER/FDA), Oluseyi Adeniyi, PhD (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Michael Pacanowski, PharmD, MPH (CDER/FDA), Oluseyi Adeniyi, PhD (CDER/FDA), Paula Hyland, PhD (CDER/FDA), Ellis Christopher, PhD (CDER/FDA), Rosane Charlab Orbach, PhD (CDER/FDA), Robert Schuck, PhD (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Snehit Prabhu, PhD (Stanford)
FDA Collaborators: Elaine Johanson (OHI/FDA), Zivana Tezak, PhD (CDRH/FDA), Richardae Araojo, PharmD (OMHHE/FDA), Christine Lee, PharmD, PhD (OMHHE/FDA)
Status: Completed
CERSI Principal Investigator: Snehit Prabhu, PhD (Stanford)
FDA Collaborators: Elaine Johanson (OHI/FDA), Zivana Tezak, PhD (CDRH/FDA), Richardae Araojo, PharmD (OMHHE/FDA), Christine Lee, PharmD, PhD (OMHHE/FDA)
Status: Completed
CERSI Principal Investigator: Joseph Wu, MD, PhD (Stanford)
FDA Collaborators: Bridget Nugent, PhD (OWH/FDA), Alexandre Ribeiro, PhD (CDER/DARS/FDA)
Status: Completed
Project #75: Whole exome sequencing in patients on immune checkpoint inhibitors to risk stratify for treatment response and immune related adverse events
CERSI Principal Investigator: Elad Ziv, MD (UCSF)
FDA Collaborators: Marc Theoret (OCE/FDA), Julie Schneider (OCE/FDA), Wenming Xiao (CDER/FDA), Maitreyee Hazarika (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Christopher Almond, MD, MPH (Stanford)
FDA Collaborators: Vasum Peiris, MD, MPH (CDRH/FDA), Brittany Caldwell, PhD (CDRH/FDA)
Status: Active
Project #79: Understanding Female-Specific Treatment Outcomes of Inflammatory Bowel Disease Using Novel Artificial Intelligence Tools
CERSI Principal Investigator: Vivek Rudrapatna, MD (UCSF)
FDA Collaborators: Artur Belov (CBER), Melissa Shapiro (CDER), Zhihua Li (CDER), Laurén Doamekpor (OWH), Susan Bersoff-Matcha (OWH), Kaveeta Vasisht (OWH), Joyce Obidi (OWH)
Status: Active
Completed Projects
CERSI Principal Investigator: Kathy Giacomini, PhD (UCSF), Timothy Meyer, MD (Stanford)
FDA Collaborators: Ruth Barratt, PhD, DVM (CDER/FDA), Lei Zhang, PhD (CDER/FDA), Shiew Mei Huang, PhD (CDER/FDA), Issam Zineh, PharmD, MPH (CDER/FDA), Ming-Liang Tan, PhD (CDER/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Lee Sanders, MD (Stanford), Bonnie Halpern-Felsher, PhD (Stanford)
FDA Collaborators: Christine Lee, PharmD, PhD (OMHHE/FDA), Richardae Araojo, PharmD, MS (OMHHE/FDA), Shelly Harris, MPH (CDER/FDA), Grace Jones, PharmD (CDER/FDA), Martin Mendoza, PhD (OMHHE/FDA), Amanda Pike-McCrudden, MAA (CDER/FDA), Lee Zwanziger (OC/FDA)
Status: Completed
CERSI Principal Investigator: Sook Wah Yee, PhD (UCSF)
FDA Collaborators: Shiew Mei Huang, PhD (CDER/FDA), Lei Zhang, PhD (CDER/FDA)
Status: Completed
Project #37: Comprehensive Assessment of Sex Differential Smoking-related Effects in Publicly Available Gene Expression Data
CERSI Principal Investigator: Russ Altman, MD, PhD (Stanford)
FDA Collaborators: Bridget Nugent, PhD (OWH/FDA), Susan Bersoff-Matcha, MD (OWH/FDA), Patricia Bradfield (OWH/FDA), Kaveeta Vasisht, MD, PharmD (OWH/FDA), Ryan Conville (OWH/FDA), Jonathan Kwan, MS (OTP/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Esteban Burchard, MD, MPH (UCSF)
FDA Collaborators: Richardae Araojo, PharmD (OMHHE/FDA)
Status: Completed
CERSI Principal Investigator: Urmimala Sarkar, MD, MPH (UCSF), Courtney Lyles, PhD (UCSF)
FDA Collaborators: Richardae Araojo, PharmD, MS (OMHHE/FDA), Christine Lee, PharmD, PhD (OMHHE/FDA), Michelle Tarver, MD, PhD (CDRH/FDA)
Status: Completed
CERSI Principal Investigator: Timothy Meyer, MD (Stanford)
FDA Collaborators: Shiew Mei Huang, PhD (CDER/FDA), Lei Zhang, PhD (CDER/FDA), Qi Liu, PhD (CDER/FDA)
Status: Completed
CERSI Principal Investigator: Janice Schwartz, MD (UCSF)
FDA Collaborators: Qi Liu, PhD, MStat (CDER/OCP/FDA), Shiew-Mei Huang, PhD (CDER/OCP/OTS/FDA)
Status: Completed
Project #71: The MUM-URMA1 study: Multimorbidity and Medications: The Unheard Perspective of Older Under-Represented Racial and Ethnic Minority Adults - Phase 1
CERSI Principal Investigator: Janice Schwartz, MD (UCSF)
FDA Collaborators: Christine Lee, PharmD, PhD (OMHHE/FDA), Qi Liu, PhD, MStat (CDER/OCP/FDA)
Status: Completed
Completed Projects
CERSI Principal Investigator: Atul Butte, MD, PhD (UCSF)
FDA Collaborators: Amy Abernethy, MD, PhD (OC/FDA)
Status: Completed
CERSI Principal Investigator: Laura Esserman, MD, MBA (UCSF)
FDA Collaborators: Mitra Rocca, Dipl. Inform. Med. (CDER/FDA), Jacqueline Corrigan-Curay, JD, MD (CDER/FDA), Dianne Paraoan (CDER/FDA), Vishal Bhatnagar, MD (OCE/FDA), Frank Weichold, MD, PhD (ORSI/FDA)
Status: Completed
CERSI Principal Investigator: Laura Esserman, MD, MBA (UCSF)
FDA Collaborators: Mitra Rocca, Dipl. Inform. Med. (CDER/FDA), Jacqueline Corrigan-Curay, JD, MD (CDER/FDA), Dianne Paraoan (CDER/FDA), Vishal Bhatnagar, MD (OCE/FDA), Frank Weichold, MD, PhD (ORSI/FDA)
Status: Completed
CERSI Principal Investigator: Rohit Vashisht, PhD (UCSF)
FDA Collaborators: Bridget Nugent, PhD (OWH/FDA), Kaveeta Vasisht, MD, PharmD (OWH/FDA), Susan Bersoff-Matcha, MD (OWH/FDA), Osman Yogurtcu, PhD (CBER/FDA), Yong Ma, PhD (CDER/FDA), Andrew Giffin, PhD (CDER/FDA) , Shuang (Sarah) Zhou, PhD (CDER/FDA)
Status: Completed | Plain Language Summary
CERSI Principal Investigator: Atul Butte, MD, PhD (UCSF), Kendra Radtke, PharmD, PhD (UCSF)
FDA Collaborators: Steven Anderson (CBER/FDA), Yun Lu (CBER/FDA), Artur Belov (CBER/FDA), Barbee Whitaker (CBER/FDA), Richard Forshee (CBER/FDA), Angela Moy (CBER/FDA), Chartrina Andrell (CBER/FDA)
Status: Completed
CERSI Principal Investigator: Atul Butte, MD, PhD (UCSF)
FDA Collaborators: Barbee Whitaker, PhD (CBER/OBE/FDA), Artur Belov, PhD (CBER/OBE/FDA), Hussein Ezzeldin, PhD (CBER/OBE/FDA), Steve Anderson, PhD (CBER/OBE/FDA), Jane Mutanga, PhD (CBER/FDA)
Status: Completed